No Subject Date 41 Wellmarker Bio Announces its latest pipeline news at the Korea Bio Investment Conference 2021 2021-12-09 40 Wellmarker Bio Receives Grand Prize at the '7th Good Company Awards' for Three Consecutive Years 2021-11-19 39 Wellmarker Bio Announces Pipeline Updates 2021-10-22 38 Wellmarker Bio Announced Successful First Subject Dosed in Phase I Clinical Study of WM-S1-030 for Treatment for Colorectal Cancer and Progressive ... 2021-07-20 37 Wellmarker Bio’s R&D Center Recognized for an Outstanding Research Capabilities 2021-06-29 36 Wellmarker Bio Presents Preclinical Data for WM-A1 at the AACR Annual Meeting 2021 2021-04-13 35 Wellmarker Bio Shares Mid and Long Term Goals at the Interview with the Medical News 2021-04-05 34 Wellmarker Bio Registers Phase I Study Plan at ClinicalTrials.gov 2021-03-19 33 Wellmarker Bio Signs CDMO Contract with Samsung Biologics 2021-03-16 32 Wellmarker Bio Shares its Plans on Clinical Trial at the Korean Economic Daily 2021-03-05 1 2 3 4 5
